Detalhe da pesquisa
1.
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.
Mol Ther
; 30(1): 485-500, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34450249
2.
NUAK family kinase 2 is a novel therapeutic target for prostate cancer.
Mol Carcinog
; 61(3): 334-345, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818445
3.
Longitudinal Tibia Stress Fracture Risk During High-Volume Training: A Multiscale Modeling Pipeline Incorporating Bone Remodeling.
J Biomech Eng
; 144(10)2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348634
4.
NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.
Breast Cancer Res Treat
; 189(1): 49-61, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196902
5.
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.
Int J Mol Sci
; 22(2)2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33429995
6.
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors.
Molecules
; 26(19)2021 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34641454
7.
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways.
Anticancer Drugs
; 31(8): 759-775, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796402
8.
Concise, gram-scale synthesis of furo[2,3-b]pyridines with functional handles for chemoselective cross-coupling.
Tetrahedron Lett
; 61(38)2020 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012852
9.
Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3.
Int J Mol Sci
; 21(21)2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33114754
10.
In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds.
Molecules
; 25(2)2020 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941153
11.
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
J Pathol
; 239(3): 320-34, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102572
12.
E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition.
EMBO J
; 38(20): e101443, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31424118
13.
Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration.
J Med Chem
; 65(2): 1313-1328, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333981
14.
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype.
ChemMedChem
; 17(12): e202200161, 2022 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403825
15.
Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor.
Oncogenesis
; 11(1): 18, 2022 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443736
16.
MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types.
Front Biosci (Landmark Ed)
; 27(5): 167, 2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638434
17.
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas.
Sci Adv
; 8(25): eabn3471, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731869
18.
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations.
Front Biosci (Landmark Ed)
; 27(6): 196, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748272
19.
Target 2035 - update on the quest for a probe for every protein.
RSC Med Chem
; 13(1): 13-21, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35211674
20.
Severe Calcaneus Injury Probability Curves Due to Under-Body Blast.
Ann Biomed Eng
; 49(11): 3118-3127, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117584